tiprankstipranks
Avalo Therapeutics (AVTX)
NASDAQ:AVTX
US Market
AVTX
Avalo Therapeutics
RESEARCH TOOLSreports

Avalo Therapeutics (AVTX) Cash flow

1,050 Followers

Avalo Therapeutics Cash Flow

AVTX's free cash flow for Q4 2025 was $-14.25M. For the 2025 fiscal year, AVTX's free cash flow was decreased by $-2.40M and operating cash flow was $-14.25M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -51.46M$ -49.06M$ -30.68M$ -26.75M$ -70.89M
Investing Cash Flow
$ -81.72M$ 356.00K$ -133.00K$ -95.00K$ -113.00K
Financing Cash Flow
$ 14.59M$ 175.85M$ 25.04M$ -14.70M$ 106.76M
End Cash Position
$ 16.11M$ 134.70M$ 7.55M$ 13.19M$ 54.86M
Free Cash Flow
$ -51.46M$ -49.06M$ -30.84M$ -26.85M$ -71.00M
Currency in USD

Avalo Therapeutics Cash Flow